This study will investigate the effects of intranasal administration of oxytocin, a social
neuropeptide, on reducing stimulant use, enhancing therapeutic engagement, and susceptibility
to stress-induced relapse in Veterans with stimulant use disorders and enrolled in opioid
replacement therapy (ORT) program for co-occurring opioid use disorder (OUD).